Sitemap
September 24, 2014 Articles
Filter by Available Specialty
- Adult diabetes rates plateau in US
- Allergan rejects Valeant reach out, Ackman threatens suit over Salix
- Amedica announces second-generation interbody fusion device
- Anti-CD19 CAR T cells show promise in chemotherapy-refractory DLBCL
- Biguanides, liraglutide reduced CVD risk in type 2 diabetes
- Brief intervention may decrease depressive symptoms in adolescents
- Choosing Wisely: Tests cardiologists should avoid
- Colorectal cancer task force issues optimal bowel prep guidelines for colonoscopy
- Corporate warfare
- DHA, EPA therapy reduced liver fat percentage in NAFLD patients
- DSM releases Dyneema Purity Radiopaque fiber
- EoE patients achieved remission with four-food group elimination diet
- FDA allows marketing of first test for yeast pathogens
- FDA approves Otezla for treatment of plaque psoriasis
- FDA competition offers $500,000 for new ideas in Salmonella detection
- FDA grants fast track designation to aramchol for NASH
- FDA: Glucose monitoring system cleared for use in critical care units
- HCV antibody decline associated with RNA clearance in MSM with HIV
- HCV tested in space
- Higher activity limitations seen with intramedullary nailing after tibial shaft fracture
- HPV vaccine initiation, parental awareness influenced by provider
- Intestinal blood flow reduced in patients with chronic HF
- Lung cancer screening of Medicare-eligible patients associated with greater benefits, risks
- Maternal breast milk primary source of postnatal CMV infection
- Metformin monotherapy increased risk for low TSH levels
- National Lipid Association issues recommendations for dyslipidemia management
- Nonagenarians experience expected rates of postoperative mortality after TKA
- NovaBay creates advisory board
- Novaliq announces positive phase 1 results for dry eye drops
- PARACHUTE III: Percutaneous ventricular restoration device safe in patients with ischemic dilated HF
- PARTNER I: TAVR delivers mortality benefit, decreases rehospitalization at 5 years
- Ramucirumab offered no benefit in metastatic HER-2–negative breast cancer
- Responses to online allergy survey fluctuated monthly, seasonally
- Screening tests helpful in identification of potential psoriatic arthritis in psoriasis patients
- Topical tranexamic acid reduced transfusion rate, cost in primary THA, TKA
- Unilateral, bilateral kyphoplasty comparable for osteoporotic vertebral compression fractures
- US diabetes rate may be leveling off